Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
fosamprenavir (lexiva) (1 trial)
icosapent ethyl (vascepa) (1 trial)
ritonavir (Norvir) (1 trial)
Hypertriglyceridemia (Phase 4)
Trials (1 total)
Trial APIs (3 total)